The Development and Use of Extracorporeal Membrane Oxygenation in Neonates

Annals of Thoracic Surgery

Volumn 76, Issue 6, 2003, Pages

  Wolfson, Philip J ^a,b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN;

ANTICOAGULATION; CONFERENCE PAPER; EXTRACORPOREAL OXYGENATION; HEART FAILURE; HIGH FREQUENCY VENTILATION; HUMAN; INFANT; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN INTENSIVE CARE; PRIORITY JOURNAL; RESPIRATORY FAILURE; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0344233285     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2003.09.003     Document Type: Conference Paper

References (31)

1. Bartlett RH. Esperanza. Trans ASAIO 1985;31:723-35.
2. Bartlett RH. Artificial organs: basic science meets critical care. J Am Coll Surg 2003;196:171-9.
3. Bartlett RH. Extracorporeal life support in the management of severe respiratory failure. Clin Chest Med 2000;21:555-61.
4. Zapol WM, Snider MT, Hill JD, et al. Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospective study. JAMA 1979;242:2193-6.
5. Alpard SK, Zwischenberger JB. Extracorporeal membrane oxygenation for severe respiratory failure. Chest Surg Clin North Am 2002;12:355-78.
6. Bartlett RH. Extracorporeal oxygenation in infants. Hosp Pract 1984;19:139-151.
7. Bartlett RH, Gazzaniga AB, Toomasian J, et al. Extracorporeal membrane oxygenation (ECMO) in neonatal respiratory failure: 100 cases. Ann Surg 1986;204:236-45.
8. Bartlett RH, Roloff DW, Cornell RG, et al. Extracorporeal circulation in neonatal respiratory failure: a prospective randomized study. Pediatrics 1985;76:479-86.
9. Kirkpatrick BV, Krummel TM, Mueller DG, et al. Use of extracorporeal membrane oxygenation for respiratory failure in term infants. Pediatrics 1983;72:872-6.
10. Truog RD. Randomized controlled trials: lessons from ECMO. Clin Res 1992;40:519-27.
11. Paneth N, Wallenstein S. Commentary. Extracorporeal membrane oxygenation and the play the winner rule. Pediatrics 1985;76:622-3.
12. O'Rourke PP, Crone RK, Vacanti JP, et al. Extracorporeal membrane oxygenation and conventional medical therapy in neonates with persistent pulmonary hypertenstion of the newborn: a prospective randomized study. Pediatrics 1989; 84:957-963.
13. Knox RA. A Harvard study on newborns draws fire. Boston Globe, August 7, 1989:25.
14. Marwick C. NIH "Research Risks Office" reprimands hospital institutional review board. JAMA 1990;263:2420.
15. Elliott SJ. Neonatal extracorporeal membrane oxygenation: how not to assess novel technologies. Lancet 1991;337:476-8.
16. Royall R. Ethics and statistics in randomized clinical trials. Stat Sci 1991;6:52-62.
17. Dworetz AR, Moya FR, Sabo B, Gross I. Survival of infants with persistent pulmonary hypertension of the newborn without ECMO. Pediatrics 1989;84:1-6.
18. UK Collaborative ECMO Trial Group. UK collaborative randomised trial of neonatal extracorporeal membrane oxygenation. Lancet 1996;348:75-82.
19. Conrad SA, Rycus PT. The registry of the extracorporeal life support organization. In: Zwischenberger JB, Steinhorn RH, Bartlett RH, eds. ECMO: extracorporeal cardiopulmonary support in critical care. 2nd ed. Ann Arbor, MI: Extracorporeal Life Support Organization, 2000:295-310.
20. ELSO Registry. Ann Arbor, MI: Extracorporeal Life Support Organization, 2002.
21. Roy BJ, Rycus P, Conrad SA, Clark RH. The changing demographics of neonatal extracorporeal membrane oxygenation patients reported to the Extracorporeal Life Support Organization (ELSO) Registry. Pediatrics 2000;106: 1334-8.
22. Hintz SR, Suttner DM, Sheehan AM. Decreased use of neonatal extracorporeal membrane oxygenation (ECMO): how new treatment modalities have affected ECMO utilization. Pediatrics 2000;106:1339-43.
23. Rais-Bahrami K, Short BL. The current status of neonatal extracorporeal membrane oxygenation. Semin Perinatol 2000;24:406-17.
24. Glass P, Wagner AE, Papero PH, et al. Neurodevelopmental status at age five years of neonates treated with extracorporeal membrane oxygenation. J Pediatr 1995;127:447-57.
25. Rais-Bahrami K, Wagner A, Coffman C, et al. Neurodevelopmental outcome in ECMO vs near-miss ECMO patients at 5 years of age. Clin Pediatr 2000;39:145-52.
26. Hofkosh D, Thompson AE, Nozza RJ, et al. Ten years of extracorporeal membrane oxygenation: neurodevelopmental outcome. Pediatrics 1991;87:549-55.
27. Schumacher RE, Palmer TW, Roloff DW, et al. Follow-up of intants treated with extracorporeal membrane oxygenation for newborn respiratory failure. Pediatrics 1991;87:451-7.
28. Kim ES, Stolar CJ. ECMO in the newborn. Am J Perinatol 2000;17:345-54.
29. Bennett CC, Johnson A, Field DJ. A comparison of clinical variables that predict adverse outcome in term infants with severe respiratory failure randomised to a policy of extracorporeal membrane oxygenation or to conventional neonatal intensive care. J Perinat Med 2002;30:225-30.
30. Schumacher RE, Roloff DW, Chapman R, et al. Extracorporeal membrane oxygenation in term newborns: a prospective cost-benefit analysis. ASAIO J 1993;39:873-9.
31. Vats A, Pettignano R, Culler S, Wright J. Cost of extracorporeal life support in pediatric patients with acute respiratory failure. Crit Care Med 1998;26:1587-92.